ENETS centre of excellence

It aimed to define specialist centres across Europe that were able to treat patients with neuroendocrine tumours. We were awarded ENETS centre of excellence status in March 2011 and again in 2014. In March 2019, we were fully re-accredited for a further five years.

In order to be accredited, centres had to:

  • see a high number of patients
  • have an established, regular multidisciplinary team meeting
  • be involved in research and clinical trials
  • be able to offer a broad range of treatments
  • be able to monitor the results of treatments
  • agree to follow treatment guidelines
  • actively involve patients in their activities (such as the NET Patient Foundation Support Group Day)
  • seek feedback from patients

Setting up a network of Centres of Excellence allows them to work with each other in collaboration, for example in the development of new treatments (through clinical trials) and in sharing best practice.    

The Christie NET service is also represented on the ENETS Advisory Board by Professor Valle.

Read more about ENETS Centers of Excellence

Last updated: October 2021

Christie stories during the COVID-19 pandemic

During the COVID-19 pandemic, we're doing all we can to make sure patients get the treatment, information and support they need. Read some stories from our patients and staff to find out what The Christie is doing at this difficult time.

View All
Corinne Faivre Finn
“We have seen a lot of our research staff return to the office. This has massively improved morale as it is a lot easier to connect with people.”
Corinne Faivre-Finn, Christie consultant
Read More
Read More
profile placeholder image
“The experience has allowed me to be able to hear what is not being said. The extraordinary strength and resilience of individuals as they greet you with a smile… when you are aware of the pain and anguish they will be going through.”
Digital services team, redeployed to telephone patients
Read More
Read More
“Of course, the COVID-19 virus has not gone away – we have to be cautious and we have to proceed in an appropriate way.”
Professor John Radford, director of research at The Christie
Read More
Read More